Iulia
Coliban is a molecular biologist, with
a current enrollment in a PhD program in Molecular Biology and Medical Genetics,
and is currently serving as a field application scientist (NGS) and scientific
researcher at the Human Molecular Genetics Laboratory, Institute of Mother and
Child, Chișinău. She received her bachelor’s degree in general biology (2013)
and master’s degree in molecular biology (2015) from the Academy of Sciences of
Moldova University and enrolled in PhD research at "N.Testemițanu" State University of
Medicine and Pharmacy. Her professional experience includes
molecular diagnostics, neonatal genetic screening, and implementation of
national clinical and laboratory protocols for genetic and rare diseases. Her current research focuses on
neonatal screening and rare disease diagnostics, particularly spinal muscular
atrophy (SMA) and translational genomics, while her previous work involved
prenatal and postnatal diagnosis of neuromuscular disorders and assay
development. She is a member of the European Society of Human Genetics (ESHG), also the International Society for Neonatal Screening (ISNS), and member of an expert panel for NBS at the Clinical and Laboratory Standards Institute. In addition,
she received gold, silver, and bronze medals at international innovation
exhibitions for her contributions to molecular diagnostic protocols.
Iulia
Coliban is a molecular biologist, with
a current enrollment in a PhD program in Molecular Biology and Medical Genetics,
and is currently serving as a field application scientist (NGS) and scientific
researcher at the Human Molecular Genetics Laboratory, Institute of Mother and
Child, Chișinău. She received her bachelor’s degree in general biology (2013)
and master’s degree in molecular biology (2015) from the Academy of Sciences of
Moldova University and enrolled in PhD research at "N.Testemițanu" State University of
Medicine and Pharmacy. Her professional experience includes
molecular diagnostics, neonatal genetic screening, and implementation of
national clinical and laboratory protocols for genetic and rare diseases. Her current research focuses on
neonatal screening and rare disease diagnostics, particularly spinal muscular
atrophy (SMA) and translational genomics, while her previous work involved
prenatal and postnatal diagnosis of neuromuscular disorders and assay
development. She is a member of the European Society of Human Genetics (ESHG), also the International Society for Neonatal Screening (ISNS), and member of an expert panel for NBS at the Clinical and Laboratory Standards Institute. In addition,
she received gold, silver, and bronze medals at international innovation
exhibitions for her contributions to molecular diagnostic protocols.